NEW YORK — Biotech company IFF recently announced the expansion of its pet portfolio with the launch of its new product, Betafin® Pet — a natural betaine that supports hydration, gut health and overall wellness in dogs and cats, according to the company. IFF stated that the launch is part of its mission to “revolutionize” companion animal care through advanced biotechnology and innovation. 

“We’re excited to bring our world-class biotechnology into the pet wellness space,” said Jordon Gruber, Ph.D., companion animal technical leader of Health & Biosciences for IFF. “Our new portfolio empowers brands to tackle key challenges, delivering standout products that enhance pet health and wellness in a competitive marketplace. From improving gut health and dental care to hydration and reducing odors, we are setting a new benchmark.” 

Other solutions within IFF’s pet portfolio include enzymes, probiotics, plant protein, as well as solutions for food protection, natural colors and flavors. The portfolio is supported by specialized R&D centers, including the Pet Translational Research Lab, Pet Enzymes Lab and Pet Applications Lab, according to IFF.

“This launch is not just about products; it’s about transforming the way we approach pet wellness,” said Brett Volmert, senior marketing leader for pets in North America, Food Ingredients, for IFF. “Pet parents are increasingly focused on their pets’ health, and manufacturers require innovative, science-backed solutions and a good understanding of functionality to meet this demand.”

Read more news from pet food and treat industry suppliers.